Onderzoeker
Valentijn Vergote
- Disciplines:Microbiologie, Systeembiologie, Laboratoriumgeneeskunde
Affiliaties
- Departement Microbiologie, Immunologie en Transplantatie (Departement)
Lid
Vanaf1 apr 2019 → Heden - Laboratorium Klinische en Epidemiologische Virologie (Rega Instituut) (Afdeling)
Lid
Vanaf1 jul 2011 → 31 mrt 2019
Publicaties
1 - 10 van 33
- Design and validation of a laboratory-developed diagnostic assay for monkeypox virus(2023)
Auteurs: Valentijn Vergote, Bert Vanmechelen, Lies Laenen, Emmanuel Andre, Marc Van Ranst, Piet Maes
Pagina's: 795 - 800 - The characterization of multiple novel paramyxoviruses highlights the diverse nature of the subfamily Orthoparamyxovirinae(2022)
Auteurs: Bert Vanmechelen, Lies Laenen, Valentijn Vergote, Piet Maes
- HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect(2022)
Auteurs: Rana Abdelnabi, Suzanne Kaptein, Sebastiaan ter Horst, Leen Delang, Joana Duarte Da Rocha Pereira, Lotte Coelmont, Pieter Leyssen, Kai Dallmeier, Valentijn Vergote, Elisabeth Heylen, et al.
- The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model(2021)
Auteurs: Rana Abdelnabi, Suzanne Kaptein, Lana Langendries, Laura Vangeel, Valentijn Vergote, Elisabeth Heylen, Pieter Leyssen, Kai Dallmeier, Lotte Coelmont, Patrick Augustijns, et al.
- Exploration of the Ixodes ricinus virosphere unveils an extensive virus diversity including novel coltiviruses and other reoviruses(2021)
Auteurs: Bert Vanmechelen, Valentijn Vergote, Lies Laenen, Marijn Thijssen, Piet Maes
- Longitudinal antibody andT cell responses in Ebola virus disease survivors and contacts: an observational cohort study(2021)
Auteurs: Piet Maes, Lies Laenen, Valentijn Vergote
Pagina's: 507 - 516 - Chloroquine, an Anti-Malaria Drug as Effective Prevention for Hantavirus Infections(2021)
Auteurs: Valentijn Vergote, Lies Laenen, Patrick Augustijns, Marc Van Ranst, Piet Maes
- Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies(2021)
Auteurs: Laurent Godinas, Yannick Van Herck, Natalie Lorent, Daan Dierickx, Geert Meyfroidt, Lore Vanderbeke, Valentijn Vergote, Katrien Lagrou, Peter Verhamme, Joost Wauters, et al.
Pagina's: 1100 - 1105 - Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease Outcomes(2021)
Auteurs: Bert Vanmechelen, Valentijn Vergote, Lies Laenen, Guy Baele, Johan Van Weyenbergh, Piet Maes
Pagina's: 76 - 84 - A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate(2020)
Auteurs: Lorena Sanchez Felipe, Thomas Vercruysse, Sapna Sharma, Ji Ma, Viktor Lemmens, Robbert Boudewijns, Bert Malengier-Devlies, Laurens Liesenborghs, Suzanne Kaptein, Madina Rasulova, et al.
Pagina's: 320 - 325